Maternal RNAs are synthesized by the oocyte during its growth; some of them are utilized for oocyte-specific processes and metabolism, others are stored and used during early development before embryonic genome activation. The appropriate expression of complex sets of genes is needed for oocyte maturation and early embryo development. In spite of the basic role of noncoding RNAs in the regulation of gene expression, few studies have analyzed their role in human oocytes. In this study, we identified the microRNAs (miRNAs) expressed in human metaphase II stage oocytes, and found that some of them are able to control pluripotency, chromatin remodeling, and early embryo development. We demonstrated that 12 miRNAs are differentially expressed in women of advanced reproductive age and, by bioinformatics analysis, we identified their mRNA targets, expressed in human oocytes and involved in the regulation of pathways altered in reproductive aging. Finally, we found the upregulation of miR-29a-3p, miR-203a-3p, and miR-494-3p, evolutionarily conserved miRNAs, also in aged mouse oocytes, and demonstrated that their overexpression is antithetically correlated with the downregulation of DNA methyltransferase 3A (Dnmt3a), DNA methyltransferase 3B (Dnmt3b), phosphatase and tensin homolog (Pten), and mitochondrial transcription factor A (Tfam). We propose that oocyte miRNAs perform an important regulatory function in human female germ cells, and their altered regulation could explain the changes occurring in oocyte aging.
INTRODUCTION
The latest data published by the Encyclopedia of DNA Elements Project Consortium reported that at least 75% of the human nuclear genome is transcribed, and most of the transcriptome is comprised of RNAs, noncoding RNAs (ncRNAs), that are not translated into proteins [1] [2] [3] . Some of them may be considered constitutive, as they are abundantly and ubiquitously expressed and provide essential functions to the cells (ribosomal RNA [rRNA] , transfer RNAs [tRNA], small nuclear RNAs [snRNA]) [3] . Others may be considered regulatory ncRNAs, since they are involved in different steps of gene expression. Regulatory ncRNAs are classified according to size as small ncRNAs ( 200 nt) or long ncRNAs (.200 nt). Small ncRNAs, including microRNAs (miRNAs), small interfering RNAs (siRNAs), and PIWI element-interacting RNAs (piRNAs), are involved in gene regulation as posttranscriptional regulators or as elements of chromatinmodifying complexes [3] . MicroRNAs are by far the most characterized, both structurally and functionally. They regulate gene expression by binding to mRNA target sites in the 3 0 untranslated region with partial or full complementarity: in the first case, miRNAs reduce translation and stability of their targets; in the second, they cause target degradation [4] . Their central biomolecular role has been amply demonstrated, and the same holds true for their involvement in human diseases: variations of their sequence, expression, and ensuing biomolecular functions have been detected in different pathologies, particularly in cancer [5, 6] . In reproductive biology, different studies have investigated the function of miRNAs in ovarian development, in oocyte differentiation, in follicular maturation, and their role in ovarian disease has been documented [7] . Oocyte differentiation occurs through protracted and complex processes beginning during embryonic life, and ends at the moment that the metaphase II stage (MII) oocyte is ovulated. The correct sequence of events, occurring during this extended period of time, as well as the constant dialog between the germ cell and somatic cells within the ovarian follicle, establish the oocyte quality and pregnancy outcome. In fact, the production of a fully competent oocyte, ready for fertilization, represents one of the most important factors contributing to reproductive success [8] .
Understanding the complex pathways regulating oocyte growth and maturation is not only important in basic research, but represents the first step in prognosis, diagnosis, and therapy in reproductive medicine, and could improve pregnancy success in assisted reproductive technology (ART). Regulation of gene expression represents one of the most important cellular processes determining oocyte quality. In fact, during growth, the oocytes accumulate RNAs (maternal RNAs) that will be used for meiosis resumption or during the first phases of development before genomic activation of the embryo [9] . Several studies have focused on mRNAs, demonstrating the importance of the oocyte transcriptome in determining oocyte quality, but, to date, very few studies are available on miRNA expression profiles in human female germ cells and on their biological function. [9] . MicroRNAs have been identified in oocytes from numerous organisms, from zebrafish to humans, but, today, their biological role remains relatively unknown, especially in humans [10] [11] [12] [13] [14] [15] [16] . Moreover, the data obtained on murine models are controversial. Mouse germ cells produce small ncRNAs; in fact, cloning and sequencing of RNAs from murine oocytes revealed three classes of small ncRNAs: miRNAs, piRNAs, and endo-siRNAs [17, 18] . In 2007, it was suggested that mouse maternal miRNAs are essential for oocyte maturation and early embryo development [19, 20] . By preventing production of miRNAs through deletion of Dicer (double-stranded RNA-processing enzyme), which catalyzes the final cytoplasmic cleavage and generates mature miRNAs, the authors observed aberrant spindles, meiosis arrest, and inhibition of zygote development [19, 20] . Some years later, other researchers, by using knockout mice for the subunit of the microprocessor complex DGCR8, found that Dgcr8 À/À oocytes develop and ovulate normally, can be fertilized, and give rise to viable mice [21] [22] [23] . Considering that Dicer is involved in the maturation of miRNAs and siRNAs, while DGCR8 seems to be involved only in the maturation of miRNAs, the authors concluded that miRNAs are not essential for oogenesis and embryo development in the mouse, and that only siRNAs and piRNAs are likely to be active in germ cells [21] [22] [23] . The loss of function of oocyte miRNAs could be distinctive of mice; in fact, in this species, an amino-terminally truncated isoform of Dicer (Dicer 0 ) is produced. Dicer 0 is essential for mouse oocyte functions, and shows particular affinity for siRNA maturation with respect to miRNAs [24] .
Further studies should address the function of miRNAs in mouse oocytes, because maturation steps specific to individual miRNAs have been uncovered [25] . In other species, miRNAs are functional and control mRNAs known to be essential for follicle growth, oocyte maturation, and embryo development [10] [11] [12] [13] [14] [15] [16] .
Decreased female fertility with advanced maternal age is well documented, and it is widely recognized that the decline in oocyte quality is a key phenomenon to explain infertility: it is associated with a higher risk of birth defects, genetic disorders, and miscarriage [26, 27] . Several papers have investigated the transcriptome of protein-encoding genes of human oocytes and its alterations related to aging, but, to our knowledge, no data on miRNA expression profiles during reproductive aging have been published [28] [29] [30] .
To identify human oocyte miRNAs and demonstrate that conditions altering oocyte quality, such as reproductive aging, can influence miRNA expression, we compared miRNA profiles in MII oocytes from young and old women who had undergone an in vitro fertilization program by using a highthroughput (HT) technology. Using a computational approach, we investigated whether differentially expressed (DE) miRNAs are able to regulate pathways involved in oocyte aging. Finally, we identified evolutionarily conserved miRNAs between humans and mice and their shared mRNA targets. We compared their expression profiles in old and young mice assessing, at the same time, the expression of miRNAs and mRNAs.
MATERIALS AND METHODS

Ethics
The study was approved by the Institutional Ethical Committee Catania 1, and all patients provided written informed consent. All the experiments on murine oocytes were carried out in accordance with the guidelines for the care and use of laboratory animals approved by the Animal Care Committee of the University of L'Aquila, Italy.
Patients and Oocyte Collection
Oocytes were donated by healthy women who had undergone intracytoplasmic sperm injections (ICSI) at the IVF Center in Cannizzaro Hospital, Catania, Italy. All patients included in this study were known to have maledependent primary infertility. These women had no endometriosis, polycystic ovaries, ovarian insufficiency, or metabolic syndromes. Finally, heavy smokers and overweight women were excluded from the study. Our exclusion criteria were designed to avoid limiting factors in female fertility, which could affect oocyte quality. Two age categories of patients were defined: women from 38 to 40 yr (older group) and women from 28 to 35 yr (younger group). Our research followed the tenets of the Declaration of Helsinki. The oocytes were collected from patients who had been treated with GnRH agonists (triptorelin or buserelin) to induce multiple follicular development, followed by ovarian stimulation with recombinant follicle-stimulating hormone and human menopausal gonadotropin. Stimulation was monitored by serum E 2 concentrations and ultrasound measurement of follicle numbers and diameters. Ovulation was induced with 10 000 IU of human chorionic gonadotropin (hCG; Gonasi), when the dominant follicles reached 18-to 20-mm diameter and the serum estradiol concentration per follicle was 150À200 ng/L. Transvaginal ultrasound-guided pickup of ovarian follicles was performed 34-36 h after hCG injection. Cumulus-enclosed oocytes were separated from follicular fluid, placed in medium, and incubated for 2 h at 378C in a humidified 5% CO 2 atmosphere. After incubation, oocytes were treated with 80 IU/ml of hyaluronidase (Synvitro Hyadase; Medicult) and then rinsed three times in culture medium (ISM1 culture medium; Origio). Special care was taken to ensure the complete lack of corona cells from oocytes in order to select the three best MII oocytes for ICSI procedures from each patient. Oocytes were evaluated by an inverted microscope at 3200 magnification for structural parameter assessment (zona pellucida, polar body, and cytoplasm). At the end of the injection, supernumerary eggs were prepared for molecular studies, choosing those with optimal morphology. A total of 12 mature MII oocytes were collected (two oocytes from each woman): six from three older women (old oocytes) and six from three younger women (young oocytes).
MicroRNA Profiling of Human Oocytes: RNA isolation miRNA Reverse Transcription, and Real-Time PCR Two MII oocytes from the same woman were placed together in an Eppendorf tube: the six samples (three from the younger group and three from the older group) were analyzed for the expression of 384 miRNAs by TaqMan Low-Density Array (TLDAs) technology (Applied Biosystem). This highly specific technology allows amplification of only mature miRNAs [31] . Each sample was rinsed several times in RNase-free water to remove any trace of cell culture medium, and then placed in water and stored at À808C. According to a previously published protocol, RNA from human oocytes was extracted by thermolysis: the samples were incubated for 1 min at 1008C in order to release nucleic acids [32] . Every sample was brought to a volume of 3.2 ll with water and directly reverse transcribed, without prior RNA purification, using TaqMan MicroRNA Reverse Transcription Kit and Megaplex RT Primers, Human Pool A (Applied Biosystems) in a final volume of 7.5 ll. Preamplification of cDNA from 2.5 ll of RT reaction product, using Megaplex PreAmp Primers Pool A and TaqMan PreAmp Master Mix (23; Applied Biosystems), was run in a final volume of 25 ll. Preamplified products were diluted with 75 ll of RNase-free purified water and 18 ll were loaded onto TLDAs, TaqMan Human MicroRNA Array v3.0 A (Applied Biosystems). Quantitative RT-PCR reactions were performed on a 7900HT Fast Real Time PCR System (Applied Biosystems) as follows: 94.58C for 10 min, followed by 40 amplification cycles of 978C for 30 sec and 59.78C for 1 min.
Expression Data Analysis
MicroRNAs with a Ct lower than 37, showing optimal amplification plots, were considered as detected, while undetermined Ct values were assigned a value of 40. A miRNA that had been detected in at least three of the six samples was considered as expressed in human oocytes.
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To normalize miRNA profiling data, median and average expression of the plate and the pairwise Pearson correlation (r) for all miRNAs were calculated to identify the more stable miRNAs that showed constant expression levels among individual samples. GeNorm and NormFinder statistical algorithms were used to confirm their stability and select the endogenous controls. GeNorm analysis revealed that miR-342-3p and miR-372 were the most stable, having both the lowest average expression stability M values (0.11). The lower the M value, the more stably expressed are the reference genes [33] . Similarly, NormFinder indicated that the combination of miR-342-3p and miR-372, having the lowest stability value (0.005), was the best [34] .
Differential expression of miRNAs between young and old oocytes was identified by significance analysis of microarrays (SAM) tests (i.e., Tusher, minimum S value, the 5th, 50th, and 90th percentiles, by applying a two-class unpaired test among DCt and using a P value based on 100 permutations; imputation engine: K-nearest neighbors, 10 neighbors; false discovery rate [FDR] , 0.30). We considered as DE only those miRNAs with two housekeeping miRNAs in common, after at least two SAM tests. The relative expression was obtained by applying the 2 ÀDDCt method. DCt values were independently calculated by using miR-342-3p and miR-372 Ct mean. DCt means of old and young oocytes were used to determine DDCt; young oocytes were chosen as calibrator. The mean fold change was calculated as a natural logarithm of relative quantification (RQ) values; the error was estimated by evaluating the 2 ÀDDCt equation, using DDCt plus SD and DDCt minus SD according to the Livak and Schmittgen method [35] . Since relative quantification with different reference miRNAs did not differ significantly and produced similar relative expression data, only RQ values obtained with the housekeeping miR-342 are shown.
In order to identify the miRNAs showing a steady expression level in every sample, we selected the miRNAs showing median and average r values greater than or equal to 0.75. The median of the DCt values (using miR-342 as the housekeeping miRNA) of old and young oocytes were used to calculate the r and P values with Statistica 10.0 (StatSoft).
Genomics of Oocyte miRNAs
Chromosome and nucleotide positions were determined by UCSC Genomic Browser (https://genome.ucsc.edu/) and the database Gene of NCBI (http:// www.ncbi.nlm.nih.gov/gene). The sequences of mature miRNAs were retrieved from MirBase (http://mirbase.org/).
Pathway Analysis of Steadily Expressed miRNAs
To investigate the role of steadily expressed (SE) miRNAs, computational analysis of molecular signaling pathways, selecting for targets retrieved from Tarbase and microT-CDS, was carried out by Diana mirPath v.3 (http:// snf-515788.vm.okeanos.grnet.gr/). The FDR method, as a correction for multiple hypotheses testing, was implemented to select the biological pathways with a threshold of significance defined by a P value , 0.05 and a microT threshold of 0.8 [36] .
Enrichment Analysis for Biological Processes and Target Gene Pathways of DE miRNAs
Validated and potential targets of DE miRNAs were searched for using a computational approach, based on a combination of three different tools: starBase v2.0, miRTarBase v4.5, and TarBase v7.0. Enrichment analysis for biological processes and target gene pathways was performed by using proteincoding genes, associated with maturation of oocytes in humans (http://okdb. appliedbioinfo.net/) [37, 38] and expressed together in aging. A list of genes involved in the physiological aging process can be obtained from GenAge, a reliable database of genes related to aging in humans and in model organisms (http://genomics.senescence.info/genes/models.html). The final target list was then uploaded to PANTHER (Protein Analysis Through Evolutionary Relationships) Classification System, version 10.0-this is a comprehensive database of protein trees, families, subfamilies, and functions (available at http://pantherdb.org), which was designed to classify proteins (and their coding genes) in order to facilitate HT analysis. The Gene Ontology (GO) analysis was applied to analyze the main functions of the target genes of DE miRNAs. The functional classification of miRNA targets was focused on GO experimentally observed biological process. The statistical overrepresentation test was executed and the Bonferroni correction for multiple testing was used to correct the P value. GOs with a P value , 0.05 were chosen. DE miRNA target genes were subsequently used in a signaling pathway enrichment analysis in DianamiRPath v2.0 (http://www.microrna.gr/miRPathv2). The predefined list of genes expressed in MII human oocytes and aging-related genes was uploaded to carry out pathway analysis of in silico predicted and experimentally validated miRNA gene targets, according to the Kyoto Encyclopedia of Genes and Genomes (KEGG). The FDR method was implemented to select the biological pathways with a threshold of significance defined by P , 0.05 and a microT threshold of 0.8 [36] .
Identification of Evolutionarily Conserved miRNAs in Humans and Mice, and Network Analysis
Among the DE miRNAs in aged human oocytes, we identified those having the same mature sequence in humans and mice deposited in miRBase 21 (http:// www.mirbase.org) and at the same time sharing the same mRNA targets. Common genes between humans and mice were screened using Diana-LAB miRNA target prediction algorithms (microT-CDS and Tarbase v7.0). A list of 7 conserved miRNAs and the 125 target genes was entered in Cytoscape version 3.2.1 for further analysis. The biological network was built by retrieving the corresponding interactome data through Cytoscape plug-in GeneMANIA v.3.4.0, selecting for physical, genetic, and pathway interactions. We generated a subnetwork with 101 nodes by taking only first neighbors between miRNAs and target genes in the network. The resulting network was analyzed using the Cytoscape plug-in, CentiScaPe v.2.1, to calculate the centrality parameters of individual nodes. The conserved miRNAs were analyzed in six aliquots of murine oocytes by single assays.
Mouse Oocyte Collection
For oocyte isolation, CD-1 young (4-5 wk) and reproductively old (36 wk) mice (very close to the end of their reproductive lifespan) were stimulated by 7.5 IU pregnant mare serum gonadotropin (Folligon; Intervet-International) to induce follicular development; 48 h later, ovulation was induced by 7.5 IU hCG (Profasi HP 2000; Serono) [39] . All experiments were carried out in accordance with the guidelines for the care and use of laboratory animals approved by the Animal Care Committee of the University of L'Aquila, Italy. At 15 h after hCG administration, oviducts were dissected from mice and cumulus-oocyte complexes (COCs) collected by puncture of the oviduct. Following dissociation of COCs in hyaluronidase 0.1% (Sigma-Aldrich), mature oocytes arrested at MII were isolated and pooled in groups of 30 oocytes. Three pools of oocytes from young mice and three from old mice were washed in RNase-free water, transferred to 10 ll of TRIzol (Life Technologies), placed in liquid nitrogen, and stored at À808C until use [40] .
Expression Analysis of miRNAs and mRNAs in Mouse Oocytes
Total RNA for expression analysis was extracted by using TRIzol, according to the protocol provided by the manufacturer. After quantification, 5 ng of total RNA was used for miRNA-specific reverse transcription to obtain miRNA-specific cDNAs. Four-fifths of the cDNA total volumes were analyzed with quantitative real-time RT-PCR using TaqMan MicroRNA Assays (Applied Biosystems). All real-time PCR reactions were performed in 20 ll volume, containing 10 ll of TaqMan Universal PCR Master Mix (Applied Biosystems), 1 ll of miRNA-specific TaqMan MicroRNA Assay, 6 ll of RT product, and 3 ll of nuclease-free water. We assayed seven miRNAs: let-7b-5p (assay ID 002619), miR-19a-3p (assay ID 000395), miR-29a-3p (assay ID 002112), miR-126-3p (assay ID 002228), miR-192-5p (assay ID 000491), miR203a-3p (assay ID 000507), and miR-494-3p (assay ID 002365). These assays specifically detect mature miRNAs. For each reaction, the following amplification profile was applied: 958C for 10 min for the first cycle; 958C for 15 sec and 608C for 1 min for 40 cycles. The results were normalized to the expression level of U6 and analyzed by the DDCt method.
To assess the expression of DE miRNA targets, conserved genes, resulting from network centrality analysis and selected from literature data, were analyzed. Primers of DNA methyltransferase 3A (Dnmt3a), DNA methyltransferase 3B (Dnmt3b), phosphatase and tensin homolog (Pten), and mitochondrial transcription factor A (Tfam) were designed using Primer-Blast software (http://www.ncbi.nlm.nih.gov/tools/primer-blast/; Supplemental Table S1 , available online at www.biolreprod.org). Complementary DNA was synthesized from 100 ng of total RNA using SuperScript II Reverse Transcriptase (Invitrogen S.R.L.) and random hexamer primers (Roche Molecular Diagnostics). PCR reactions were carried out by Power SYBR Green PCR Master Mix kit (Applied Biosystem) in a final volume of 20 ll containing 2 ll of cDNA. 
Statistical Analysis
The mean DCT and the SD of the mean were calculated using the statistical function of Microsoft Excel 2010. Statistical significance was determined by unpaired t-test (two-tailed) from DCt values of the old oocytes and controls. The miRNA-target correlation was determined by the Pearson correlation test. P 0.05 was considered statistically significant.
RESULTS
MicroRNA Profiling of Human MII Oocytes
Expression profiles of 384 miRNAs in 6 old and 6 young human oocytes showed that 128 miRNAs are expressed in human female germ cells. The comparison between old and young oocytes showed that 25 had steady expression levels in every sample (r ¼ 0.96, P , 0.0001; SE miRNAs; Fig. 1A ). On the other hand, 12 miRNAs displayed significant expression differences in oocytes from women of advanced reproductive age (DE miRNAs; Fig. 1B) . Among the 12 miRNAs displaying significant expression differences with aging, we found 3 miRNAs strongly downregulated in oocytes from older women: let-7b-5p (ln RQ ¼ À4.6 6 0.23), miR-19a-3p (ln RQ ¼À3.5 6 0.42), miR-519d-3p (ln RQ ¼À5.4 6 0.23) (Fig.  1C) . In contrast, nine miRNAs, (let-7e-5p, miR-29a-3p, miR-126-3p, miR-136-5p, miR-192-5p, miR-203a-3p, miR-371-3p, miR-484, and miR-494-3p) were upregulated (Fig. 1C) . Among them, miR-192-5p and miR-203a-3p showed RQ values about 100-fold (ln RQ ¼ 4.6 6 1.29) and 78-fold (ln RQ ¼ 4.3 6 0.97) higher in old oocytes (Fig. 1C) . A total of 91 miRNAs, even if detected, displayed high variability among the different samples ( Table 1) .
The genomics of SE and DE miRNAs reveal the presence of some clustered miRNAs (Table 2) . We found five miRNAs of the 17-92 cluster, three in C14MC (chromosome 14 miRNA cluster), three in miR-371 cluster, six in C19MC (chromosome 19 miRNA cluster), and four in miR-106a cluster (Table 2) . Six miRNAs presented a paralogous gene located in a different genomic region, sharing the same mature sequence; it was not possible to discriminate them by expression studies. Nine miRNAs shared all the AAGUGC sequences described in miRNAs involved in stemness and pluripotency [41] (Fig. 2) . 
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Gene Target Prediction, GO, and Pathway Analysis of SE and DE miRNAs
Bioinformatics analysis of SE miRNAs showed their involvement in different biological pathways; the most significant are shown in Figure 3 . All 25 miRNAs are able to control signaling pathways regulating pluripotency of stem cells, targeting mRNAs involved in proliferation, differentiation, and regulation of the cell cycle (Fig. 3) .
The 12 DE miRNAs were predicted to regulate 1638 protein-coding genes. In order to make a more specific analysis, we interpolated these targets with specific oocyte genes and human aging-related genes: with this strategy, we reduced the number of DE miRNA targets from 1638 to 153 (Fig. 4A ). Among these 153 mRNAs, 27 could be of particular interest, because they are common between oocyte genes and aging (Fig. 4A) . The GO analysis of the 153 candidate target genes showed that the following GO categories were highly and significantly represented: regulation of gene expression; cell cycle process; chromosome organization; RNA metabolic process; response to stress; apoptotic process; chromatin modification and remodeling; response to oxygen-containing compounds; cell aging; cellular senescence; and signal transduction in response to DNA damage (Fig. 4B) . Candidate target genes were found to be significantly enriched in 13 KEGG pathways (P , 0.05; Fig. 4C ). Notably, these include mTOR, VEGF, phosphatidylinositol 3-kinase (PI3K)-Akt, ErbB, insulin, p53, HIF1 signaling pathways, progesteronemediated oocyte maturation, endometrial cancer, cell cycle, oocyte meiosis, and dorsoventral axis formation (Fig. 4C) .
Network Analysis for the Identification of miRNAs and mRNAs Shared Between Humans and Mice
Among the 12 DE miRNAs in aged human oocytes, we selected 7 evolutionarily conserved miRNAs for sequence and functions. First of all, we identified 10 miRNAs (let-7b-5p, let7e-5p, miR-19a-3p, miR-29a-3p, miR-126-3p, miR-136-5p, miR-192-5p, miR-203a-3p, miR-484, and miR-494-3p) as having 100% identity between humans and mice (www. mirbase.org/). Among them, seven miRNAs (let-7b-5p, miR19a-3p, miR-29a-3p, miR-126-3p, miR-192-5p, miR-203a-3p, and miR-494-3p) also shared orthologous target genes, thus also showing functional homology. In Figure 5 , we show the interactions among the 7 miRNAs and some conserved mRNAs. The network, consisting of 101 nodes and 532 edges (gene relationship, pathway involvement, physical interactions), shows 51 common nodes representing human-mouse orthologous protein-encoding genes (blue circles and red diamonds). Particularly, 20 of them (ADSS, ALCAM, BRWD1, DNMT3A, DNMT3B, EDN1, EFNB2, FOXJ2, PTEN, PURA, RAP1A, RAP1B, RBFOX2, RHOB, RICTOR, RRM2, SOCS3, STK38, TFAM, and UBE2A) are important topological orthologs (red diamonds) with degree . 6.4, betweenness . 0.0042, closeness . 40.5, and eccentricity . 0.25 (Fig. 5) .
Expression Analysis of Age-Related miRNAs and Their mRNA Targets in Mouse Oocytes
The seven miRNAs that share sequence and functional homology (yellow nodes in the network) were analyzed by single assays in mice. We found upregulation of four of them: mir-29a-3p (ln RQ ¼ 1.5 6 0.29), miR-192-5p (ln RQ ¼ 1.3 6 0.64), miR-203a-3p (ln RQ ¼ 1.8 6 0.36), and miR-494-3p (ln RQ ¼ 1.5 6 1.26) (Fig. 6 ). Statistical analysis confirmed that expression differences of miR-29a-3p, miR-203a-3p, and miR-494-3p are significant (Fig. 6) . Mir-19a-3p, miR-126-3p, and let-7b-5p are expressed in murine oocytes, but their expression levels do not change in aging. We selected four mRNAs validated targets of miR-29a, miR-203, and miR-494-3p belonging to the 20 important topological orthologs in the network (red diamonds); specifically, Dnmt3a (miR-29a-3p target), Dnmt3b (miR-29a-3p and miR-203a-3p target), Pten (miR-29a-3p and miR-203a-3p target), and Tfam (miR-494-3p target) [42] [43] [44] [45] [46] [47] [48] [49] [50] . We found a significant downregulation of each messenger and demonstrated a significant negative correlation between miR-29a-3p and its targets (Dnmt3a, Dnmt3b, Pten) between miR-203a-3p and Dnmt3b, and between miR-494-3p and Tfam (Fig. 6 ).
DISCUSSION
Maternal RNAs represent an important store that oocytes accumulate during their growth, determine oocyte quality, and establish embryo features. Several studies have focused on mRNAs, demonstrating the importance of the oocyte transcriptome; however, to date, very limited studies are available on miRNA expression profiles in human female germ cells and on their biological function. To date, ncRNAs are considered very important regulators of gene expression; thus, it seems logical to hypothesize that miRNAs could perform their biological role in female germ cells during maturation or in the first phases of embryo development. Accordingly, their altered expression could lead to low-quality oocytes and therefore contribute to reproductive disorders [4] [5] [6] .
In this paper, we report the identification of 128 miRNAs expressed in human oocytes (Table 1) . Among them, 25 showed a steady expression in every sample (SE miRNAs), 12 were DE in oocytes from women of advanced reproductive age, and 91 showed high variability among the different samples within the same group (Table 1 and Fig. 1 ). Among this last fraction, we found miRNAs previously identified in human oocytes (miR-10a, miR-100, miR-141, miR-212, miR-625, and miR-888) [14, 15] . The high variability of expression could depend on interindividual differences able to influence the transcriptome, such as genetic background or life styles [9] .
The 25 SE miRNAs regulate some pathways involved in basic cellular function, such as RNA transport, mRNA surveillance, and regulation of the actin cytoskeleton. Moreover, it is interesting that signaling pathways regulating pluripotency of stem cells is one of the most significant (Fig.  3) .
The well-characterized embryonic stem cells miRNome includes the miR-371-373 cluster family (the miR-290-295 cluster in the mouse), the miR-17-92 cluster and its paralogues located in the miR-106 cluster, and the miR-302/miR-467 group [41] . Most of these display the 5 0 -proximal AAGUGC motif that seems to be typical of embryonic miRNAs (EmiRNAs) [41] . We found different members of the first three clusters SE in human oocytes (Fig. 2) . We also found some members of C19MC, which is a primate-specific cluster, and has been described as mainly expressed in placenta (Fig. 2 ) [51] . This represents the largest human cluster, and we propose that some members could be classified as EmiRNAs, because we found the AAGUGC motif conserved in the four identified miRNAs (Fig. 2) . Moreover, previous papers have reported that some miRNAs located in this cluster are expressed in human embryonic stem cells [52] . It has been reported that EmiRNAs are expressed during early mammalian development, and their earliest known role is during maternal-zygotic transition, when zygotic transcription starts and maternal mRNAs are degraded [41, 53] . We propose that SE miRNAs are part of the maternal storage of essential RNAs, which oocytes synthesize during their growth, and perform their role during the first phase of embryo development. Similar to pluripotential factors, Oct3/4, Sox2, Klf4, and c-Myc, expressed in human oocytes, these miRNAs could represent the oocyte store able to reprogram the nucleus of somatic cells. If oocytes are devoid of this storage, they are not able to produce a vital embryo. Therefore, these miRNAs represent molecular markers of oocyte quality. Stronger data, suggesting an active role of miRNAs in human oocytes, report that some of them showed altered MicroRNAs AND HUMAN OOCYTES expression in reproductive aging, a condition that causes a reduction of reproductive efficiency and alters oocyte quality by modifying gene expression [26] [27] [28] [29] [30] . We found 12 DE miRNAs in oocytes from women of advanced reproductive age, and, by bioinformatics analysis, we demonstrated that DE miRNAs contribute to the alteration of oocyte pathways that is characteristic in aging [28] [29] [30] [54] [55] [56] . The functional role of miRNA targets in human oocytes was accurately evaluated and a comprehensive computational analysis of deregulated miRNAs in oocyte aging was performed. One of the main problems with miRNA target prediction tools is that the software retrieves all mRNAs able to be regulated by input miRNAs without making a selection based on tissue specificity or particular functions. This means that a lot of messengers are retrieved, and further analysis, based on these predictions, lacks specificity. To avoid this problem, we performed an enrichment analysis and, out of 1638 mRNA targets identified initially, we selected 153 mRNAs representing specific oocyte genes and human aging-related genes (Fig. 4A) . Based on these 153 targets, identified GO terms overlapped with GO categories previously identified by studying mRNAs deregulated in oocyte aging (Fig. 4B) [28] [29] [30] [54] [55] [56] . We found genes related to cell cycle, chromosome organization, stress response, DNA stability, modulation of chromatin architecture, management of oxygen, the response to DNA damage, and regulation of the apoptotic process, which have been described to be altered by age, in mouse and human MII oocytes (Fig.  4B) [28, 30, 54] . Pathway analysis identified genes involved in oocyte maturation (progesterone-mediated oocyte maturation, mTOR, PI3K-AKT, and ErbB signaling pathways) and pinpointed the major pathways involved in aging (P53, mTOR, and cell cycle signaling pathways), in agreement with previously published papers (Fig. 4C) [29, 55] . These data confirmed that the identified miRNAs are involved in oocyte aging.
The strategies used to control gene expression have many similarities between humans and mice, even if mouse oocytes do not necessarily represent an ideal model to study the regulation of gene expression carried out by miRNAs. Moreover, in our study, we found different members of primate-specific cluster C19MC expressed in human oocytes and absent in the mouse [51] . Nevertheless, the mouse model could represent a good alternative, and could be used to confirm human data because of poor availability of human oocytes. We drew a network showing the molecular interaction among the seven conserved miRNAs (let-7b-5p, miR-19a-3p, miR-29a-3p, miR-126-3p, miR-192-5p, miR-203a-3p, and miR-494-3p), and their target genes were identified by the enrichment analysis. In the network, in addition to humanspecific targets (black circles), we identified orthologous genes (blue circles and red diamonds), and, among these, the most central nodes (red diamonds) (Fig. 5) . This network could represent a starting point for translating results from mice to humans.
We analyzed the seven conserved miRNAs in mouse oocytes and confirmed the upregulation of miR-29a-3p, miR203a-3p, and miR-494-3p in old mice.
Integrating centrality results with data from the literature, we selected Dnmt3a, Dnmt3b, Pten, and Tfam (central nodes and validated targets of miR-29a-3p, miR-203a-3p, and miR-494-3p) and analyzed their expression in the same aliquots of mouse oocytes. We found the corresponding downregulation of all mRNAs (Fig. 6) .
It has been demonstrated in different cellular models that miR-29a and miR-203 regulate de novo DNMT3A and DNMT3B in humans and mice [42, 49, 57] .
DNA methylation is an epigenetic mechanism essential for chromatin remodeling and regulation of gene expression in mammals. It is important for embryonic development, imprinting, X-chromosome inactivation, and the maintenance of genome stability by the repression of retrotransposons [58] . Dnmt3a and Dnmt3b are responsible for de novo methylation, and play critical roles during gametogenesis and, above all, in early development [59] [60] [61] [62] . During the oocyte growth phase, before meiosis resumption, DNMT3s establish the oocyte methylation patterns and mark a subset of genes for activity in the embryo, such as imprinted genes [59, 60] . During the early phases of embryo development, subsequent to demethylation waves needed for genome reprogramming and to reach the totipotent state, de novo methylation contributes to the first lineage specification allowing the differentiation between trophoectoderm and inner cell mass [61, 62] . The aging phenotype is influenced by epigenetic modifications, alteration of DNA methylation increases with increasing age, and may predispose to age-associated diseases [63] . In addition, in reproductive biology, alteration of DNA methylation levels related to aging has been seen in oocytes and preimplantation embryos [64] . Genome-wide DNA methylation is lower in 35-to 40-wk-old mouse oocytes, and DNMT expression is also decreased in aged oocytes [54, 65, 66] . Moreover, it has been shown that their decreasing expression may be related to a lower reproductive potential in old female mice and, in human oocytes, altered expression of DNMT3B is associated with low oocyte quality [66, 67] .
We found miR-29a-3p and miR-203a-3p upregulated in old human and mouse oocytes, and demonstrated, in the mouse model, that their overexpression correlates with Dnmt3a and Dnmt3b downregulation (Figs. 3 and 5 ). According to data in the literature, we found the downregulation of Dnmt3s in aging, and identified human and mouse oocyte miRNAs involved in their altered regulation. The identification of miRNAs regulating DNMT3s in oocytes could open up the possibility of improving oocyte quality in aging, and also in reproductive disorders [68, 69] .
PTEN, a validated target of miR-29a-3p and miR-494-3p, is an indispensable molecule that maintains the dormancy of the primordial follicle pool, inhibiting the PI3K signaling pathway [44, 45, 70, 71] . Its downregulation represents an important step in the cyclical activation of primordial follicles. The depletion of the primordial follicle pool leads to the end of female reproductive life, and it has been demonstrated that, in   FIG. 4 . Target prediction, GO, and pathway enrichment analysis for DE miRNAs with age. A) Venn diagram showing the overlap between miRNA targets and the number of genes that were identified in oocytes and related to aging. Targets that overlapped these three different data sets are listed (126 in green box and 27 in orange box). B) Significant GOs, in terms of experimentally observed biological processes, for DE miRNAs identified in human MII oocytes, are shown. The x-axis represents the Àlog10 (P value); the significance was determined by the adjusted Bonferroni correction. C) Signaling pathway heat map regulated by DE miRNAs. Pathway enrichment analysis with KEGG against listed target genes identifies the potential role of miRNA in reproductive aging. The probability values are reported as Àlog10 (P value). Gray boxes indicate that the pathway is not significant.
MicroRNAs AND HUMAN OOCYTES mice lacking Pten, the entire primordial follicle pool becomes activated, causing premature ovarian failure [70] . The significant downregulation of Pten found in older oocytes could be closely associated with the decrease of ovarian reserve, a hallmark of aging [71] . In addition, the PI3K pathway is involved in other steps of follicular maturation: acting in granulose cells, it regulates cyclic follicular recruitment and ovulation, while it stimulates meiosis resumption in oocytes [72] . The modulation of PTEN levels, inside ovarian follicles, requires a fine regulation that could be carried out by miR-29a-3p and miR-494-3p [73] . Moreover, their overexpression and the resulting PTEN downregulation related to aging could have a negative effect on the embryo, because it has been seen that PTEN is essential for embryonic development [74] . Our data show a significant upregulation of miR-494-3p associated with the downregulation of Tfam in older oocytes. The TFAM gene encodes a key mitochondrial transcription factor, and is able to regulate the mtDNA copy number [75] . It has been demonstrated that miR-494-3p is able to regulate mitochondrial biogenesis by downregulating TFAM during myocyte differentiation and skeletal muscle adaptation to physical exercise [47] . TFAM is expressed in mammalian oocytes. It has been shown that expression of mRNAs is higher in human MII oocytes compared with GV and MI oocytes, and a recent study has demonstrated that bovine oocytes with low developmental competence and cleavage failure exhibit a lower expression of TFAM [76] [77] [78] [79] . The miR-494 upregulation in old human and mouse oocytes related to downregulation of TFAM could explain the lower number of mitochondria associated with oocyte aging [80, 81] .
We characterized miRNA profiles in human oocytes, identifying the expression differences in reproductive aging. These data advance our knowledge on the oocyte transcriptome, and represent the first step to improving prognosis, diagnosis, and, eventually, therapy in reproductive medicine.
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